Shares of Schrodinger, Inc. (NASDAQ:SDGR – Get Free Report) have been assigned a consensus recommendation of “Hold” from the eight brokerages that are covering the firm, MarketBeat Ratings reports. One equities research analyst has rated the stock with a sell recommendation, three have issued a hold recommendation and four have assigned a buy recommendation to the company. The average 12 month price target among brokerages that have issued a report on the stock in the last year is $26.2857.
SDGR has been the subject of several analyst reports. Morgan Stanley lowered their target price on shares of Schrodinger from $28.00 to $19.00 and set an “equal weight” rating for the company in a report on Monday, August 18th. Wall Street Zen lowered shares of Schrodinger from a “hold” rating to a “sell” rating in a research note on Saturday, October 4th. Barclays assumed coverage on shares of Schrodinger in a research note on Thursday, August 14th. They issued an “overweight” rating and a $25.00 price objective for the company. KeyCorp decreased their price target on Schrodinger from $30.00 to $28.00 and set an “overweight” rating for the company in a research report on Wednesday. Finally, Weiss Ratings reaffirmed a “sell (d-)” rating on shares of Schrodinger in a research report on Saturday, September 27th.
View Our Latest Analysis on SDGR
Institutional Trading of Schrodinger
Schrodinger Stock Up 2.8%
Shares of NASDAQ:SDGR opened at $20.72 on Friday. Schrodinger has a twelve month low of $16.60 and a twelve month high of $28.47. The stock’s 50 day moving average is $19.57 and its 200-day moving average is $21.36. The firm has a market capitalization of $1.53 billion, a price-to-earnings ratio of -8.35 and a beta of 1.74.
Schrodinger (NASDAQ:SDGR – Get Free Report) last issued its quarterly earnings data on Wednesday, August 6th. The company reported ($0.59) EPS for the quarter, topping the consensus estimate of ($0.83) by $0.24. The firm had revenue of $54.76 million during the quarter, compared to the consensus estimate of $52.03 million. Schrodinger had a negative return on equity of 45.70% and a negative net margin of 76.22%.The company’s quarterly revenue was up 15.7% compared to the same quarter last year. During the same period in the prior year, the business posted ($0.66) earnings per share. Equities research analysts anticipate that Schrodinger will post -2.37 earnings per share for the current fiscal year.
Schrodinger Company Profile
Schrödinger, Inc, together with its subsidiaries, develops physics-based computational platform that enables discovery of novel molecules for drug development and materials applications. The company operates in two segments, Software and Drug Discovery. The Software segment is focused on licensing its software to transform molecular discovery for life sciences and materials science industries.
Read More
- Five stocks we like better than Schrodinger
- What Are Dividends? Buy the Best Dividend Stocks
- Lowe’s vs. Home Depot: Which Benefits More From Lower Rates?
- What is diluted earnings per share (Diluted EPS)?
- These 5 Beaten-Down Tech Stocks Could Catch Fire Next
- Stock Ratings and Recommendations: Understanding Analyst Ratings
- Falcon Flex Drives Growth as CrowdStrike Bets on AI Security
Receive News & Ratings for Schrodinger Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Schrodinger and related companies with MarketBeat.com's FREE daily email newsletter.